FDA Biologics (BLA & Biosimilars)Original article
OTAT Town Hall: Clinical Development of Gene Therapy Products for Rare Diseases - 02/07/2023
ConferenceNeutral
AI Analysis
Summary
The FDA's CBER Office of Tissues and Advanced Therapies is hosting a virtual town hall on February 7, 2023 to address stakeholder questions regarding clinical development of gene therapy products for rare diseases.
Importance:2/10
Sentiment:
0.00
gene therapyrare diseasesFDA guidanceCBERclinical development
Related Companies
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on September 9, 2026 6:03 PM